Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Manprit Chohan"'
Autor:
Vinod Chandran, Louis Bessette, Carter Thorne, Maqbool Sheriff, Proton Rahman, Dafna D. Gladman, Sabeen Anwar, Jennifer Jelley, Anne-Julie Gaudreau, Manprit Chohan, John S. Sampalis
Publikováno v:
Rheumatology and Therapy, Vol 11, Iss 2, Pp 443-455 (2024)
Abstract Introduction The APPRAISE study was conducted to better understand the 12-month effectiveness, tolerability, and patient satisfaction with apremilast treatment for patients with psoriatic arthritis (PsA) in real-world settings. Methods APPRA
Externí odkaz:
https://doaj.org/article/e0c68fb386474728b01333870b8c7130
Autor:
Michael R Marit, Manprit Chohan, Natasha Matthew, Kai Huang, Douglas A Kuntz, David R Rose, Dwayne L Barber
Publikováno v:
PLoS ONE, Vol 7, Iss 8, p e43437 (2012)
The non-receptor tyrosine kinase JAK2 is implicated in a group of myeloproliferative neoplasms including polycythemia vera, essential thrombocythemia, and primary myelofibrosis. JAK2-selective inhibitors are currently being evaluated in clinical tria
Externí odkaz:
https://doaj.org/article/71edbe4ec5af46f3bd7c1c259ac9a289
Autor:
Manprit Chohan, Natalie Stickle, Adrienne Halupa, Barbara A. Miller, Dwayne L. Barber, Bryan K. Beattie
Publikováno v:
Experimental Cell Research. 309:1-11
Red blood cell development is primarily controlled by erythropoietin (EPO). Several studies have revealed the importance of EPO-R Y343 and Y479 for erythroid cell growth, differentiation, and survival. In order to isolate critical signaling proteins
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::934c229557b51c51e13901e48938cafb
https://doi.org/10.1016/j.yexcr.2005.04.030
https://doi.org/10.1016/j.yexcr.2005.04.030
Publikováno v:
Trends in Cell Biology. 15:146-155
Erythropoietin (EPO) is the crucial cytokine regulator of red blood-cell production. Since the discovery of EPO in 1985 and the isolation of its cognate receptor four years later, there has been significant interest in understanding the unique abilit
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9cd75f3122edbdaae2d346d443e6fea5
https://doi.org/10.1016/j.tcb.2005.01.007
https://doi.org/10.1016/j.tcb.2005.01.007
Publikováno v:
Blood. 112:3717-3717
Mutation and activation of JAK2 is a common event in Myeloproliferative Disease as JAK2 V617F and related deletion mutations are observed in Polycythemia Vera, Essential Thrombocythemia and Primary Myelofibrosis. In addition, the TEL-JAK2 chromosomal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::07e170363183a57365f43373ace64c3f
https://doi.org/10.1182/blood.v112.11.3717.3717
https://doi.org/10.1182/blood.v112.11.3717.3717
Publikováno v:
Blood. 108:1151-1151
Friend-virus mediated erythroleukemia is a well-established model of murine oncogenesis. Several host factors have been shown to be necessary for Friend-mediated infection including a productive interaction between the Erythropoietin Receptor (EPO-R)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cd555c5aff0bec8fe202e4eab517377e
https://doi.org/10.1182/blood.v108.11.1151.1151
https://doi.org/10.1182/blood.v108.11.1151.1151